Science and Medicine
Press Releases
May 2008
Novel sight saving device in trials at King’s College Hospital, London
(PDF, 56k)
April 2008
FDA Grants NeoVista’s Request to Expand CABERNET Trial to 30 Sites in the U.S.
(PDF, 39k)
NeoVista Receives CE Mark Approval to Distribute Wet AMD Device in Europe
(PDF, 43k)
March 2008
NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society
(PDF, 42k)
February 2008
NeoVista presents a revolutionary new treatment for Wet Age-related Macular Degeneration
(PDF, 19k)
November 2007
First European Patient Treated in CABERNET Trial with Novel Treatment for Wet AMD
(PDF, 28k)
NeoVista, Inc. Presents New Data on Its Novel Wet AMD Therapy at AAO
(PDF, 28k)
June 2007
NeoVista, Inc. Reports Commencement of CABERNET Clinical Trial for the Treatment of Age-Related Macular Degeneration
(PDF, 10k)
March 2007
NeoVista, Inc. Reports Positive 6 Month Concomitant Study Results on Wet AMD therapy
(PDF, 69k)
January 2007
NeoVista, Inc. Reports Positive Study Results on Wet AMD Therapy
(PDF, 16k)
December 2006
NeoVista, Inc. Closes $41M Series "C" Financing Round
(Word doc, 25k)
Media Contact
Mr. Tony Moses
Vice President of Marketing & Sales
NeoVista, Inc.
47865 Fremont Blvd.
Fremont, CA 94538
Office: 510.933.7600
Fax: 510.933.7659
news@neovistainc.com
Media Content
The NeoVista Epi-Rad 90TM Ophthalmic System
(114M .wmv, please allow time for download)
News segment: NeoVista News Coverage in San Antonio
News segment: NeoVista News Coverage in San Antonio (2)
News segment: Investigational Device from NeoVista
Fact Sheet
Fact Sheet as an Adobe Acrobat file. (76 KB in .pdf format).
(Note: Free download of Adobe Acrobat Reader from the Adobe Web Site.